Back to top
Pharmaceuticals Ultrasector Profund, Service Class: (MF: PHPSX)
(NASDAQ Mutual Funds) As of Jan 15, 2026 05:34 PM ET
$28.51 USD
-0.62 (-2.13%)
Zacks MF Rank
NA
Latest Performance as of Dec 31, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 40.02 | 10 |
| 3 months | 24.79 | 5 |
| 6 months | 58.07 | 5 |
| 1 Year | 40.02 | 10 |
| 3 Year | 7.30 | 55 |
| 5 Year | 4.81 | 53 |
| 10 Year | 4.33 | 98 |
* Annual for three years and beyond.
Mutual Funds Research & Tools
Search Similar Mutual Funds
Research similar Mutual Funds with higher ranks and performance ratings.
Mutual Funds Comparison View (minimum of 2)
Mutual Funds Screener
Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.
Portfolio Statistics
| % Unrealized Gain | 28.38 |
| % Yield | 0.00 |
| % SEC Yield | NA |
| Net Assets (Mil $) 12/31/2025 | 0.32 |
| % Turnover 12/31/2025 | 178.00 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 1.10 | 0.84 | 1.07 |
| Alpha | -11.61 | -4.89 | -8.37 |
| R Squared | 0.20 | 0.24 | 0.43 |
| Std. Dev. | 29.33 | 25.66 | 24.69 |
| Sharpe | 0.23 | 0.19 | 4.00 |
Sector / Country Weightings
| As of 12/31/2025 | % of Portfolio |
|---|---|
| Health | 60.82 |
| Other | 33.99 |
| Retail Trade | 1.68 |
| Industrial Cyclical | 1.50 |
| Services | 1.19 |
| Non-Durable | 0.82 |
Portfolio Holdings
| Top Equity Holdings (As of 10/31/2025) |
% of Portfolio | Value (Mil$) |
|---|---|---|
| TOTAL*REPURCHASE AGREEMEN | 16.88 | 0.55 |
| TOTAL*OTHER | 10.59 | 0.34 |
| CRINETICS PHARMACEUTICALS | 2.24 | 0.07 |
| ELANCO ANIMAL HEALTH INC | 2.18 | 0.07 |
| LIGAND PHARMACEUTICALS IN | 2.08 | 0.07 |
| ELI LILLY & CO | 2.05 | 0.07 |
| SUPERNUS PHARMACEUTICALS | 2.15 | 0.07 |
| TARSUS PHARMACEUTICALS IN | 2.28 | 0.07 |
| AXSOME THERAPEUTICS INC | 1.96 | 0.06 |
Stock Holding % of Net Assets
| As Of | 10/31/2025 |
| Total Issues | 51 |
| Avg. P/E | 20.35 |
| Avg. P/Book | 6.72 |
| Avg. EPS Growth | 12.1 |
| Avg. Market Value (Mil $) | 54,495 |
Composition
| % of Portfolio | |
| Stocks | 72.53 |
| Foreign Stocks | 3.64 |
| Cash | 16.88 |
| Bonds | 0.00 |
| Foreign Bonds | 0.00 |
| Preferred | 0.00 |
| Convertible | 0.00 |
| Other | 10.59 |
| Foreign Hedged | 0.00 |
Style Analysis
| % of Portfolio | |
| Large Growth | 0.00 |
| Large Value | 1.34 |
| Small Growth | 12.44 |
| Small Value | 0.00 |
| Foreign Stock | 0.00 |
| Emerging Market | 0.00 |
| Precious Metal | 0.10 |
| Intermediate Bond | 10.39 |
| Foreign Bond | 0.00 |
| High Yield Bond | 0.93 |